PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50122C00010 — THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF A SECOND-GENERATION, MULTI-ANALYTE MOLECULAR SARS-COV-2 AND INFLUENZA A/…

THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF A SECOND-GENERATION, MULTI-ANALYTE MOLECULAR SARS-COV-2 AND INFLUENZA A/… is a federal NONE award for Department of Health and Human Services (HHS) held by DETECT, INC.. Estimated value $25.5M ($25.5M obligated). Current period of performance ends Oct 26, 2026. Last award drew 1 bidder.

$25.5M
Estimated Value
Oct 26, 2026
PoP End / Expires
1
Bidders (last award)
DETECT, INC.
Incumbent

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

DETECT, INC. holds $2.6M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Oct 26, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50122C00010
AgencyDepartment of Health and Human Services (HHS)
IncumbentDETECT, INC.
UEIT9JGP21Q2XU3
NAICS541715
PSC6505
PoP end (current)Oct 26, 2026
Obligated$25.5M

THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF A SECOND-GENERATION, MULTI-ANALYTE MOLECULAR SARS-COV-2 AND INFLUENZA A/B TEST THAT HAS A REDUCED TIME TO RESULT AND INCREASED SENSITIVITY THAT CAN BE USED AT HOME OR A POC SETTING

Recompete timing

Public
Expiring in 70 days

Current PoP ends Oct 26, 2026 (70 days remaining). Agencies typically plan 12–18 months ahead — at 2.3 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

DETECT, INC.$2.6M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$2.6M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75A50122C00010
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open DETECT, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50122C00010?

75A50122C00010 (THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF A SECOND-GENERATION, MULTI-ANALYTE MOLECULAR SARS-COV-2 AND INFLUENZA A/…) is a Department of Health and Human Services (HHS) award with an estimated value of $25.5M, currently held by DETECT, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50122C00010?

DETECT, INC. is the incumbent with $2.6M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Oct 26, 2026.

When does 75A50122C00010 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 26, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50122C00010